Dr. Blanco on the Role of Pathology in Treatment of Breast Cancer

Luis Z. Blanco Jr., MD
Published: Friday, Oct 12, 2018



Luis Z. Blanco Jr., MD, assistant professor of pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer in an interview with OncLive during the Lynn Sage Breast Cancer Symposium.

During his presentation at the symposium, Blanco explained that an oncologist chose a lesser-common patient case to discuss. Similar to a virtual tumor board, each specialist in the session discussed how they would manage this patient's disease.  

Blanco says that his role in breast cancer treatment is in looking at the tissue through a breast biopsy to evaluate what kind of tumor is present. He relays that information to his colleagues who are then able to decide what treatment they need to use for the patient.

View more from the 2018 Lynn Sage Breast Cancer Symposium


Luis Z. Blanco Jr., MD, assistant professor of pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer in an interview with OncLive during the Lynn Sage Breast Cancer Symposium.

During his presentation at the symposium, Blanco explained that an oncologist chose a lesser-common patient case to discuss. Similar to a virtual tumor board, each specialist in the session discussed how they would manage this patient's disease.  

Blanco says that his role in breast cancer treatment is in looking at the tissue through a breast biopsy to evaluate what kind of tumor is present. He relays that information to his colleagues who are then able to decide what treatment they need to use for the patient.

View more from the 2018 Lynn Sage Breast Cancer Symposium

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x